{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "BNT162b2 vaccine",
      "SARS-CoV-2",
      "neutralizing antibodies",
      "variant of concern",
      "variant of interest"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34092181",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "12",
    "Day": "04"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1080/22221751.2021.1940305"
    ],
    "Journal": {
      "ISSN": "2222-1751",
      "JournalIssue": {
        "Volume": "10",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Dec"
        }
      },
      "Title": "Emerging microbes & infections",
      "ISOAbbreviation": "Emerg Microbes Infect"
    },
    "ArticleTitle": "Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.",
    "Pagination": {
      "StartPage": "1241",
      "EndPage": "1243",
      "MedlinePgn": "1241-1243"
    },
    "Abstract": {
      "AbstractText": [
        "In this study, we show that BNT162b2 vaccine-elicited antibodies efficiently neutralize SARS-CoV-2 authentic viruses belonging to B.1, B.1.1.7, B.1.351, B.1.525 and P.1 lineages. Interestingly, the neutralization of B.1.1.7 and B.1.525 lineages was significantly higher, whereas the neutralization of B.1.351 and P.1 lineages was robust but significantly lower as compared to B.1 lineage. Following our findings, we consider that the BNT162b2 vaccine offers protection against the current prevailing variants of SARS-CoV-2."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."
          }
        ],
        "LastName": "Zani",
        "ForeName": "Alberto",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."
          }
        ],
        "LastName": "Caccuri",
        "ForeName": "Francesca",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."
          }
        ],
        "LastName": "Messali",
        "ForeName": "Serena",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."
          }
        ],
        "LastName": "Bonfanti",
        "ForeName": "Carlo",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy."
          }
        ],
        "LastName": "Caruso",
        "ForeName": "Arnaldo",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Letter"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Emerg Microbes Infect",
    "NlmUniqueID": "101594885",
    "ISSNLinking": "2222-1751"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Neutralizing"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "N38TVC63NU",
      "NameOfSubstance": "BNT162 Vaccine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Antibodies, Neutralizing"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "BNT162 Vaccine"
    },
    {
      "QualifierName": [
        "immunology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neutralization Tests"
    },
    {
      "QualifierName": [
        "classification",
        "genetics",
        "immunology"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "No potential conflict of interest was reported by the author(s)."
}